William Blair & Company
MRVI icon

William Blair & Company’s Maravai LifeSciences MRVI Stock Holding History

William Blair & Company’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,566
Closed -$87.8K – 1859
2024
Q3 		$87.8K Sell
10,566
-85,052
-89% -$735K ﹤0.01% 1555
2024
Q2 		$685K Sell
95,618
-3,156
-3% -$27.2K ﹤0.01% 992
2024
Q1 		$856K Sell
98,774
-2,188
-2% -$14.8K ﹤0.01% 918
2023
Q4 		$661K Sell
100,962
-165,298
-62% -$1.07M ﹤0.01% 991
2023
Q3 		$2.66M Sell
266,260
-118,632
-31% -$1.3M 0.01% 588
2023
Q2 		$4.78M Sell
384,892
-219,152
-36% -$2.96M 0.02% 462
2023
Q1 		$8.46M Sell
604,044
-265,277
-31% -$3.81M 0.03% 333
2022
Q4 		$12.4M Buy
869,321
+81,077
+10% +$1.28M 0.05% 270
2022
Q3 		$20.1M Buy
788,244
+96,045
+14% +$2.41M 0.09% 182
2022
Q2 		$19.7M Sell
692,199
-16,201
-2% -$513K 0.09% 197
2022
Q1 		$25M Sell
708,400
-4,348
-0.6% -$146K 0.09% 198
2021
Q4 		$29.9M Sell
712,748
-456,532
-39% -$18.5M 0.09% 192
2021
Q3 		$57.4M Buy
1,169,280
+196,650
+20% +$9.59M 0.2% 118
2021
Q2 		$40.6M Buy
972,630
+462,000
+90% +$17.9M 0.14% 152
2021
Q1 		$18.2M Buy
510,630
+477,576
+1,445% +$15.8M 0.07% 227
2020
Q4 		$927K Buy
+33,054
New +$920K ﹤0.01% 873

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company's MRVI Position: Q4 2024 in Review

William Blair & Company sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 10,566 shares — an estimated $87.8K sold.

William Blair & Company first reported a position in MRVI in Q4 2020 and held it in 16 quarters. The position peaked at $57.4M in Q3 2021. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • William Blair & Company reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • William Blair & Company sold 10,566 Maravai LifeSciences shares in Q4 2024, an estimated $87.8K.
  • William Blair & Company first reported a position in Maravai LifeSciences in Q4 2020 and held it in 16 quarters.
  • William Blair & Company's Maravai LifeSciences position peaked at $57.4M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on William Blair & Company's 13F filing for Q4 2024, filed 12 Feb 2025.